Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 25006011)

1.

Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study.

Lim TH, Gane E, Moyes C, Borman B, Cunningham C.

Gut. 2015 Jun;64(6):966-72. doi: 10.1136/gutjnl-2013-306247. Epub 2014 Jul 8.

PMID:
25006011
2.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
3.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.

4.

Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.

Hsu HY, Chang MH, Ni YH, Jeng YM, Chiang CL, Chen HL, Wu JF, Chen PJ.

J Infect Dis. 2013 Apr;207(7):1047-57. doi: 10.1093/infdis/jis943. Epub 2013 Jan 8.

6.

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

7.

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.

Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, You SL, Iloeje UH, Chen CJ; REVEAL-HBV Study Group.

Gastroenterology. 2010 Aug;139(2):474-82. doi: 10.1053/j.gastro.2010.04.048. Epub 2010 Apr 29.

PMID:
20434450
8.

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.

Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Batrla-Utermann R, Wang LY, You SL, Hsiao CK, Chen PJ, Chen CJ; R.E.V.E.A.L.-HBV Study Group.

Gut. 2014 Oct;63(10):1648-57. doi: 10.1136/gutjnl-2013-305785. Epub 2013 Nov 13.

PMID:
24225939
9.

HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.

Kim GA, Lim YS, An J, Lee D, Shim JH, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ.

Gut. 2014 Aug;63(8):1325-32. doi: 10.1136/gutjnl-2013-305517. Epub 2013 Oct 25.

PMID:
24162593
10.

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.

Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, Williams J, Livingston SE.

Hepatology. 2010 May;51(5):1531-7. doi: 10.1002/hep.23464.

PMID:
20087968
11.

Loss of hepatitis B surface antigen in a real-life clinical cohort of patients with chronic hepatitis B virus infection.

Habersetzer F, Moenne-Loccoz R, Meyer N, Schvoerer E, Simo-Noumbissie P, Dritsas S, Baumert TF, Doffoël M.

Liver Int. 2015 Jan;35(1):130-9. doi: 10.1111/liv.12661. Epub 2014 Sep 15.

PMID:
25145784
12.

Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.

Fung J, Seto WK, Wong DK, Lai CL, Yuen MF.

Liver Int. 2015 Mar;35(3):854-9. doi: 10.1111/liv.12596. Epub 2014 Jun 4.

PMID:
24840542
13.

A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection.

Minuk GY, Macrury S, Uhanova J, Caouette S, Coleman N, Cummings K, Larke B, Vardy L, Triet Huyn C, Osiowy C.

J Viral Hepat. 2013 Dec;20(12):890-6. doi: 10.1111/jvh.12121. Epub 2013 May 29.

PMID:
24304459
14.

Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.

Tai DI, Tsay PK, Chen WT, Chu CM, Liaw YF.

Am J Gastroenterol. 2010 May;105(5):1102-9. doi: 10.1038/ajg.2009.669. Epub 2010 Mar 2.

PMID:
20197760
15.

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

McMahon BJ, Holck P, Bulkow L, Snowball M.

Ann Intern Med. 2001 Nov 6;135(9):759-68.

PMID:
11694101
16.

Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.

Ferreira SC, Chachá SG, Souza FF, Teixeira AC, Santana RC, Villanova MG, Zucoloto S, Ramalho LN, Perdoná GS, Passos AD, Martinelli AL.

Ann Hepatol. 2014 Nov-Dec;13(6):762-70.

PMID:
25332262
17.

No inflammation? No cancer! Clear HBV early and live happily.

Villa E, Fattovich G.

J Hepatol. 2010 May;52(5):768-70. doi: 10.1016/j.jhep.2010.01.018. Epub 2010 Feb 18.

18.

Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen.

Tong MJ, Nguyen MO, Tong LT, Blatt LM.

Clin Gastroenterol Hepatol. 2009 Aug;7(8):889-93. doi: 10.1016/j.cgh.2009.04.012. Epub 2009 Apr 24.

PMID:
19394445
19.

Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.

Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, Koutsounas S, Vafiadis I, Nikolopoulou G, Giannoulis G, Germanidis G, Papatheodoridis G, Touloumi G.

J Hepatol. 2013 Nov;59(5):949-56. doi: 10.1016/j.jhep.2013.07.005. Epub 2013 Jul 10.

PMID:
23850875
20.

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I, Lau K, Yuen JC, Lai CL.

Gastroenterology. 2008 Oct;135(4):1192-9. doi: 10.1053/j.gastro.2008.07.008. Epub 2008 Jul 16.

PMID:
18722377
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk